Cargando…
Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors
OBJECTIVE: Evaluation of the impact of lower uterine segment involvement (LUSI) in type II endometrial cancer, and mutational profile of uterine papillary serous carcinomas (UPSC). METHODS: Retrospective cohort study comparing patients with type II endometrial cancer with LUSI to patients without LU...
Autores principales: | Kogan, Liron, Octeau, David, Amajoud, Zainab, Abitbol, Jeremie, Laskov, Ido, Ferenczy, Alex, Pelmus, Manuela, Eisenberg, Neta, Kessous, Roy, Lau, Susie, Yasmeen, Amber, Gotlieb, Walter H., Salvador, Shannon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003406/ https://www.ncbi.nlm.nih.gov/pubmed/29915797 http://dx.doi.org/10.1016/j.gore.2018.03.004 |
Ejemplares similares
-
Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsy
por: Octeau, David, et al.
Publicado: (2019) -
Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
por: Philip, Charles-André, et al.
Publicado: (2017) -
Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents
por: Matanes, Emad, et al.
Publicado: (2021) -
Biguanides in combination with olaparib limits tumorigenesis of drug‐resistant ovarian cancer cells through inhibition of Snail
por: Wang, Qiong, et al.
Publicado: (2019) -
Molecular markers in uterine serous cancer: Correlation between endometrial biopsy and hysterectomy specimens
por: Lokich, Elizabeth, et al.
Publicado: (2019)